Munich - Delayed Quote GBP

(STDG.MU)

Compare

94.58

+0.11

(+0.11%)

At close: 5:03 PM GMT+1

Arrowhead Pharma, Sarepta TX ink new gene therapy deal

Arrowhead Pharmaceuticals (ARWR) has secured a new partnership with Sarepta Therapeutics (SRPT). Under the terms of the deal, Sarepta will pay Arrowhead $500 million upfront and make a $325 million equity investment to gain access to Arrowhead's gene silencing technologies, which are focused on developing treatments for rare genetic diseases affecting muscles, the central nervous system, and lungs. Market Domination Co-hosts Julie Hyman and Josh Lipton break down the companies stock reactions to the news. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Angel Smith

Yahoo Finance Video 17 minutes ago

SRPT

ARWR
Best Buy CEO on potential Trump tariffs: Consumers will bear the brunt

The potential of increased tariffs just got more real.

Yahoo Finance 35 minutes ago

COST

SN

BBY
Inflection AI CEO says it's done trying to make next generation AI models

Just last year, Inflection AI was as hot as a startup could be, releasing best-in-class AI models it claimed could outperform technology from OpenAI, Meta, and Google. That's a stark contrast compared to today, as Inflection's new CEO tells TechCrunch that his startup is simply no longer trying to compete on that front. Between then and now, there's of course been a major change at Inflection. Microsoft hired then-CEO Mustafa Suleyman to run its own AI business, and paid the startup $650 million

TechCrunch 2 hours ago

MSFT
Amgen stock slips as obesity drug study disappoints Wall Street

Amgen (AMGN) fell sharply during Tuesday's intraday trading following the release of phase two trial results for its monthly obesity drug MariTide. Despite the medication demonstrating the ability to reduce an individual's body weight by 20%, the stock tumbled as the results fell short of investor expectations. Yahoo Finance Health Reporter Anjalee Khemlani delves into the details of the study, exploring the potential strategic routes Amgen could pursue to position the drug competitively in the growing GLP-1 weight loss market. To watch more expert insights and analysis on the latest market action, check out more Catalysts here. This post was written by Angel Smith

Yahoo Finance Video 4 hours ago

AMGN
Kohl’s cuts forecast, tariff impact looms

Kohl's (KSS) has lowered its annual forecast following weaker-than-expected third-quarter results, causing shares to drop by nearly 20%. The retailer also announced that CEO Tom Kingsbury will step down in January, after less than two years in the role. CFRA analyst Zachary Warring joins Morning Brief Co-hosts Seana Smith and Brad Smith to discuss the CEO transition and the company’s challenging months ahead. Warring notes that department stores are facing long-term headwinds, including the potential impact of President-elect Donald Trump’s proposed tariffs, which would impose an additional 10% tax on goods imported from China. Since apparel relies heavily on imports from China, Warring cautions that the sector is likely to be “hit the hardest.” To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. This post was written by Cindy Mizaku.

Yahoo Finance Video 6 hours ago

KSS
Amgen shows 20% weight loss in once-monthly injectable MariTide

Amgen's latest once-monthly weight loss drug data looks "OK," analysts say, as its path to approval still remains murky.

Yahoo Finance 7 hours ago

NONOF

NVO

LLY
Kohl's announces CEO shakeup ahead of Q3 earnings

Kohl's (KSS) announced that CEO Tom Kingsbury will be stepping down from the role effective January 15, 2025. Michaels Companies CEO Ashley Buchanan has been named his replacement. In the release, Kohl's says Kingsbury will serve in an advisory role and stay on the company's board through his retirement in May 2025. Yahoo Finance Senior Reporter Brooke DiPalma reports on the breaking details. To watch more expert insights and analysis on the latest market action, check out more Asking for a Trend here. This post was written by Stephanie Mikulich.

Yahoo Finance Video 23 hours ago

KSS
MicroStrategy spends $5.4 billion buying another 55,000 bitcoins, shares slide

MicroStrategy continues to add bitcoin to its balance sheet, buying another $5 billion worth of the token last week.

Yahoo Finance 23 hours ago

BTC-USD

MSTR
Dell Stock Slips As Revenue Misses Forecasts Despite Earnings Beat

Dell Technologies stock tumbled late Tuesday after the tech hardware company reported mixed fiscal third quarter results. Dell said in a news release that it earned an adjusted $2.15 per share on sales of $24.4 billion for the October-ended quarter. Analysts polled by FactSet projected the Round Rock, Texas-based company would post adjusted earnings of $2.06 per share on sales of $24.7 billion.

Investor's Business Daily 3 minutes ago

DELL
Dow Jones, S&P 500 At New High After Fed Minutes; Dell, Workday, CrowdStrike Report (Live Coverage)

The Dow Jones Industrial Average fell after news that President-elect Trump may impose tariffs on goods from China, Mexico and Canada.

Investor's Business Daily 8 minutes ago

ZM

BBY

ADI
Dell's third-quarter revenue misses on PC weakness

Dell reported revenue of $24.37 billion in the quarter, compared with the average analyst estimate of $24.67 billion, according to data compiled by LSEG. Despite booming demand for Dell's AI-optimized servers used to handle large AI workloads, its traditional PC segment has been facing stiff competition from rivals such as HP and weaker consumer spending amid an uncertain economy. Revenue from Dell's client solutions group, which houses its PC business, came in at $12.13 billion, below expectations of $12.43 billion.

Reuters 14 minutes ago

DELL
Microsoft Corp (MSFT) and LTIMindtree Partner to Accelerate AI Transformation

We recently published a list of 15 AI News Updates Investors Should Not Miss. In this article, we are going to take a look at where Microsoft Corporation (NASDAQ:MSFT) stands against other AI news updates investors should not miss. A latest report into the adoption of AI in the United Kingdom has revealed that even […]

Insider Monkey 16 minutes ago

MSFT
Dell Technologies Delivers Third Quarter Fiscal 2025 Financial Results

Full storyDell Technologies (NYSE: DELL) announces financial results for its fiscal 2025 third quarter. Revenue was $24.4 billion, up 10% year over year. Operating income was $1.7 billion and non-GAAP operating income was $2.2 billion, both up 12% year over year. Diluted earnings per share was $1.58, and non-GAAP diluted earnings per share was $2.15, up 16% and 14% year over year, respectively.

PR Newswire 18 minutes ago

DELL
Workday Announces Fiscal 2025 Third Quarter Financial Results

Workday, Inc. (NASDAQ: WDAY), a leading provider of solutions to help organizations manage their people and money, today announced results for the fiscal 2025 third quarter ended October 31, 2024.

PR Newswire 22 minutes ago

WDAY
Workday Names Rob Enslin President, Chief Commercial Officer

Workday, Inc. (NASDAQ: WDAY), a leading provider of solutions to help organizations manage their people and money, today announced the appointment of Rob Enslin to the newly created role of president, chief commercial officer (CCO). Enslin will be responsible for driving Workday's revenue growth and leading the company's global sales, partnership and customer experience efforts.

PR Newswire 22 minutes ago

WDAY
Arrowhead Pharmaceuticals Reports 2024 Fiscal Year-End Results

PASADENA, Calif., November 26, 2024--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its 2024 fiscal year ended September 30, 2024. The Company is hosting a conference call today, November 26, 2024, at 4:30 p.m. ET to discuss the results.

Business Wire 23 minutes ago

ARWR
Why Amazon Stock Is Gaining Today

New analyst coverage is bullish on Amazon's AI business.

Motley Fool 26 minutes ago

AMZN
Amazon.com (AMZN) and IBM: Launching Powerful AI Partnerships at AWS re:Invent

We recently published a list of 10 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a look at where Amazon.com, Inc. (NASDAQ:AMZN) stands against other trending AI stocks on latest news and ratings. Latest reports suggest that the United Kingdom is launching a Laboratory for AI Security […]

Insider Monkey 1 hour ago

AMZN

IBM
These Stocks Are Moving the Most Today: GM, Amgen, Lilly, Super Micro, Best Buy, Rivian, NRG Energy, Kohl’s, and More

Shares of General Motors and Ford fall after President-elect Donald Trump announces his tariff plans, while Amgen tumbles as weight-loss drug data disappoints Wall Street.

Barrons.com 1 hour ago

CRWD

RIVN

SMCI
EXCLUSIVE: Tim Draper Predicts Bitcoin To Reach $120K By End Of 2024, $250K In 2025

Tim Draper, a prominent venture capitalist and cryptocurrency enthusiast, has made Bitcoin price predictions since 2014. That year, Draper predicted Bitcoin to be $10,000 by the end of 2017. Despite skepticism, his forecast proved accurate, as Bitcoin hit $10,000 in November 2017 during its dramatic bull run. In 2018, Draper forecast Bitcoin to reach $250,000 by the end of 2022. This bold prediction was not fully realized, though Bitcoin did reach an all-time high of approximately $69,000 in Nov

Benzinga 1 hour ago

MSTR

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

(STDG.MU)

Related News

Arrowhead Pharma, Sarepta TX ink new gene therapy deal

Best Buy CEO on potential Trump tariffs: Consumers will bear the brunt

Inflection AI CEO says it's done trying to make next generation AI models

Amgen stock slips as obesity drug study disappoints Wall Street

Kohl’s cuts forecast, tariff impact looms

Amgen shows 20% weight loss in once-monthly injectable MariTide

Kohl's announces CEO shakeup ahead of Q3 earnings

MicroStrategy spends $5.4 billion buying another 55,000 bitcoins, shares slide

Dell Stock Slips As Revenue Misses Forecasts Despite Earnings Beat

Dow Jones, S&P 500 At New High After Fed Minutes; Dell, Workday, CrowdStrike Report (Live Coverage)

Dell's third-quarter revenue misses on PC weakness

Microsoft Corp (MSFT) and LTIMindtree Partner to Accelerate AI Transformation

Dell Technologies Delivers Third Quarter Fiscal 2025 Financial Results

Workday Announces Fiscal 2025 Third Quarter Financial Results

Workday Names Rob Enslin President, Chief Commercial Officer

Arrowhead Pharmaceuticals Reports 2024 Fiscal Year-End Results

Why Amazon Stock Is Gaining Today

Amazon.com (AMZN) and IBM: Launching Powerful AI Partnerships at AWS re:Invent

These Stocks Are Moving the Most Today: GM, Amgen, Lilly, Super Micro, Best Buy, Rivian, NRG Energy, Kohl’s, and More

EXCLUSIVE: Tim Draper Predicts Bitcoin To Reach $120K By End Of 2024, $250K In 2025